Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache
- PMID: 10974014
- PMCID: PMC381292
- DOI: 10.1172/JCI10909
Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache
Comment on
-
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.J Clin Invest. 2000 Apr;105(8):1049-56. doi: 10.1172/JCI9259. J Clin Invest. 2000. PMID: 10772649 Free PMC article.
-
Insulin resistance and cardiovascular disease.J Clin Invest. 2000 Aug;106(4):453-8. doi: 10.1172/JCI10762. J Clin Invest. 2000. PMID: 10953019 Free PMC article. Review. No abstract available.
-
Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.J Clin Invest. 2000 Aug;106(4):467-72. doi: 10.1172/JCI10843. J Clin Invest. 2000. PMID: 10953021 Free PMC article. Review. No abstract available.
-
Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.J Clin Invest. 2000 Aug;106(4):523-31. doi: 10.1172/JCI10370. J Clin Invest. 2000. PMID: 10953027 Free PMC article.
References
-
- Mokdad AH, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA. 1999;282:1519–1522. - PubMed
-
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607. - PubMed
-
- Misbin RI, et al. Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med. 1998;338:265–266. - PubMed
-
- Spiegelman BM. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998;47:507–514. - PubMed
-
- Brown KK, et al. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes. 1999;48:1415–1424. - PubMed
